Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ITPR3 antisense RNA 1 (ITPR3-AS1)
- Target
- ITPR3-AS1
- Molecular classification
- long non-coding RNA, antisense RNA
01
Overview
ITPR3 antisense RNA 1 (ITPR3-AS1) is a long non-coding RNA transcribed from the antisense strand of the ITPR3 genomic locus. It does not encode a protein. Instead, like other antisense RNAs, it is thought to regulate the expression of the neighboring ITPR3 gene, potentially through epigenetic or transcriptional mechanisms such as transcriptional interference, alteration of chromatin structure, or RNA-RNA interactions[3]. While ITPR3 itself is an intracellular calcium channel and has recognized roles in cell physiology, ITPR3-AS1's precise biological roles and clinical significance remain to be fully characterized. Due to its molecular class (non-coding RNA), it is not considered a classical therapeutic target.
- Other names
- ITPR3-AS1
02
Mechanism of action
Not applicable for drugs; as a non-coding RNA, it may act by transcriptional interference, chromatin remodeling, or post-transcriptional regulation of ITPR3.
03
Biological functions
Regulation of gene expression (particularly of ITPR3 gene via antisense mechanisms)epigenetic regulationpotential roles in cellular transcriptionpotential roles in chromatin structure
04
Disease associations
Potential roles in diseases in which ITPR3 expression is implicated, such as cancer (e.g., cholangiocarcinoma, liver diseases), based on its possible regulation of ITPR3. ITPR3-AS1-specific disease functions require further validation.
Beyond the preview
Go deeper on ITPR3 antisense RNA 1 (ITPR3-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ITPR3 antisense RNA 1 (ITPR3-AS1).